1. Introduction
2. Materials and Methods
3. Results
4. Discussion
Acknowledgments
Author Contributions
Conflicts of Interest
References
- Weycker, D.; Hansen, G.L.; Seifer, F.D. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chronic Respir. Dis. 2017. [Google Scholar] [CrossRef] [PubMed]
- McDonnell, M.J.; Jary, H.R.; Perry, A.; MacFarlane, J.G.; Hester, K.L.; Small, T.; Molyneux, C.; Perry, J.D.; Walton, K.E.; De Soyza, A. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of pseudomonas persistence and resistance. Respir. Med. 2015, 109, 716–726. [Google Scholar] [CrossRef] [PubMed]
- Weycker, D.; Edelsberg, J.; Oster, G.; Tino, G. Prevalence and economic burden of bronchiectasis. Clin. Pulm. Med. 2005, 12, 205–209. [Google Scholar] [CrossRef]
- Joish, V.N.; Spilsbury-Cantalupo, M.; Operschall, E.; Luong, B.; Boklage, S. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective. Appl. Health Econ. Health Policy 2013, 11, 299–304. [Google Scholar] [CrossRef] [PubMed]
- Evans, D.J.; Bara, A.I.; Greenstone, M. Prolonged antibiotics for purulent bronchiectasis. Cochrane Database Syst. Rev. 2003. [Google Scholar] [CrossRef]
- O'Donnell, A.E. Bronchiectasis. Chest 2008, 134, 815–823. [Google Scholar] [CrossRef] [PubMed]
- Felix, L.M.; Grundy, S.; Milan, S.J.; Armstrong, R.; Harrison, H.; Lynes, D.; Spencer, S. Dual antibiotics for non-cystic fibrosis bronchiectasis (protocol). Cochrane Database Syst. Rev. 2017. [Google Scholar] [CrossRef]
- Cole, P.J. Inflammation: A two-edged sword—the model of bronchiectasis. Eur. J. Respir. Dis. Suppl. 1986, 147, 6–15. [Google Scholar] [PubMed]
- Wilson, R.; Aksamit, T.; Aliberti, S.; De Soyza, A.; Elborn, J.S.; Goeminne, P.; Hill, A.T.; Menendez, R.; Polverino, E. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Respir. Med. 2016, 117, 179–189. [Google Scholar] [CrossRef] [PubMed]
- Wilson, C.B.; Jones, P.W.; O'Leary, C.J.; Hansell, D.M.; Cole, P.J.; Wilson, R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur. Respir. J. 1997, 10, 1754–1760. [Google Scholar] [CrossRef] [PubMed]
- Chalmers, J.D.; Goeminne, P.; Aliberti, S.; McDonnell, M.J.; Lonni, S.; Davidson, J.; Poppelwell, L.; Salih, W.; Pesci, A.; Dupont, L.J.; et al. The bronchiectasis severity index. An international derivation and validation study. Am. J. Respir. Crit. Care Med. 2014, 189, 576–585. [Google Scholar] [CrossRef] [PubMed]
- Goeminne, P.C.; Scheers, H.; Decraene, A.; Seys, S.; Dupont, L.J. Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: A retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients. Respir. Res. 2012, 13, 21. [Google Scholar] [CrossRef] [PubMed]
- Davies, G.; Wells, A.U.; Doffman, S.; Watanabe, S.; Wilson, R. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur. Respir. J. 2006, 28, 974–979. [Google Scholar] [CrossRef] [PubMed]
- McShane, P.J.; Naureckas, E.T.; Strek, M.E. Bronchiectasis in a diverse US population: Effects of ethnicity on etiology and sputum culture. Chest 2012, 142, 159–167. [Google Scholar] [CrossRef] [PubMed]
- Goeminne, P.C.; Nawrot, T.S.; Ruttens, D.; Seys, S.; Dupont, L.J. Mortality in non-cystic fibrosis bronchiectasis: A prospective cohort analysis. Respir. Med. 2014, 108, 287–296. [Google Scholar] [CrossRef] [PubMed]
- Evans, S.A.; Turner, S.M.; Bosch, B.J.; Hardy, C.C.; Woodhead, M.A. Lung function in bronchiectasis: The influence of Pseudomonas aeruginosa. Eur. Respir. J. 1996, 9, 1601–1604. [Google Scholar] [CrossRef] [PubMed]
- Martinez-Garcia, M.A.; Soler-Cataluna, J.J.; Perpina-Tordera, M.; Roman-Sanchez, P.; Soriano, J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007, 132, 1565–1572. [Google Scholar] [CrossRef] [PubMed]
- Guan, W.J.; Gao, Y.H.; Xu, G.; Lin, Z.Y.; Tang, Y.; Li, H.M.; Lin, Z.M.; Zheng, J.P.; Chen, R.C.; Zhong, N.S. Characterization of lung function impairment in adults with bronchiectasis. PLoS ONE 2014, 9, e113373. [Google Scholar] [CrossRef] [PubMed]
- Rogers, G.B.; van der Gast, C.J.; Cuthbertson, L.; Thomson, S.K.; Bruce, K.D.; Martin, M.L.; Serisier, D.J. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 2013, 68, 731–737. [Google Scholar] [CrossRef] [PubMed]
- Chalmers, J.D.; Smith, M.P.; McHugh, B.J.; Doherty, C.; Govan, J.R.; Hill, A.T. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit. Care Med. 2012, 186, 657–665. [Google Scholar] [CrossRef] [PubMed]
- Rogers, G.B.; Zain, N.M.; Bruce, K.D.; Burr, L.D.; Chen, A.C.; Rivett, D.W.; McGuckin, M.A.; Serisier, D.J. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann. Am. Thorac. Soc. 2014, 11, 496–503. [Google Scholar] [CrossRef] [PubMed]
- Loebinger, M.R.; Wells, A.U.; Hansell, D.M.; Chinyanganya, N.; Devaraj, A.; Meister, M.; Wilson, R. Mortality in bronchiectasis: A long-term study assessing the factors influencing survival. Eur. Respir. J. 2009, 34, 843–849. [Google Scholar] [CrossRef] [PubMed]
- Hill, A.T.; Routh, C.; Welham, S. National BTS bronchiectasis audit 2012: Is the quality standard being adhered to in adult secondary care? Thorax 2014, 69, 292–294. [Google Scholar] [CrossRef] [PubMed]
- McShane, P.J.; Naureckas, E.T.; Tino, G.; Strek, M.E. Non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit. Care Med. 2013, 188, 647–656. [Google Scholar] [CrossRef] [PubMed]
- King, P.T.; Holdsworth, S.R.; Freezer, N.J.; Villanueva, E.; Holmes, P.W. Microbiologic follow-up study in adult bronchiectasis. Respir. Med. 2007, 101, 1633–1638. [Google Scholar] [CrossRef] [PubMed]
- Yayan, J.; Ghebremedhin, B.; Rasche, K. Antibiotic resistance of Pseudomonas aeruginosa in pneumonia at a single university hospital center in Germany over a 10-year period. PLoS ONE 2015, 10, e0139836. [Google Scholar] [CrossRef] [PubMed]
- Tunney, M.M.; Einarsson, G.G.; Wei, L.; Drain, M.; Klem, E.R.; Cardwell, C.; Ennis, M.; Boucher, R.C.; Wolfgang, M.C.; Elborn, J.S. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am. J. Respir. Crit. Care Med. 2013, 187, 1118–1126. [Google Scholar] [CrossRef] [PubMed]
- Langton Hewer, S.C.; Smyth, A.R. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst. Rev. 2017, 4, CD004197. [Google Scholar] [CrossRef] [PubMed]
- Quintiles IMS. Available online: http://www.imshealth.com/en (accessed on 20 September 2017).
- Elixhauser, A.; Steiner, C.; Harris, D.R.; Coffey, R.M. Comorbidity measures for use with administrative data. Med. Care 1998, 36, 8–27. [Google Scholar] [CrossRef] [PubMed]
- Stuart, B.; Lin, J.H.; Mogayzel, P.J., Jr. Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis. Paediatr. Respir. Rev. 2010, 11, 177–184. [Google Scholar] [CrossRef] [PubMed]
- Pasteur, M.C.; Bilton, D.; Hill, A.T.; British Thoracic Society Bronchiectasis non-CF Guideline Group. British thoracic society guideline for non-CF bronchiectasis. Thorax 2010, 65, i1–i58. [Google Scholar] [CrossRef] [PubMed]
- Vendrell, M.; de Gracia, J.; Olveira, C.; Martinez, M.A.; Giron, R.; Maiz, L.; Canton, R.; Coll, R.; Escribano, A.; Sole, A. Diagnosis and treatment of bronchiectasis. Spanish society of pneumology and thoracic surgery. Archivos de Bronconeumología 2008, 44, 629–640. [Google Scholar] [CrossRef] [PubMed]
- Pressler, T.; Bohmova, C.; Conway, S.; Dumcius, S.; Hjelte, L.; Hoiby, N.; Kollberg, H.; Tummler, B.; Vavrova, V. Chronic Pseudomonas aeruginosa infection definition: EuroCareCF working group report. J Cyst. Fibros. 2011, 10, S75–S78. [Google Scholar] [CrossRef]


N | % | |
---|---|---|
Total | 716 | 100 |
Mean | ||
0–17 years | 22 | 3.07 |
18-49 years | 54 | 7.54 |
50+ years | 636 | 88.83 |
Unknown | 4 | 0.56 |
Sex | ||
Female | 433 | 60.47 |
Male | 282 | 39.39 |
Unknown | 1 | 0.14 |
Comorbidities | ||
Chronic obstructive pulmonary disease | 619 | 86.45 |
Arterial hypertension, uncontrolled | 355 | 49.58 |
Cardiac arrhythmias | 205 | 28.63 |
Fluid and electrolyte disorders | 149 | 20.81 |
Diabetes, uncontrolled | 148 | 20.67 |
Congestive heart failure | 118 | 16.48 |
Valvular disease | 108 | 15.08 |
Depression | 100 | 13.97 |
Hypothyroidism | 99 | 13.83 |
Weight loss | 90 | 12.57 |
Rheumatoid arthritis | 86 | 12.01 |
Peripheral ulcer disease | 77 | 10.75 |
Tumor | 76 | 10.61 |
Other neurological disease | 73 | 10.2 |
Pulmonary circulation disease | 69 | 9.64 |
Deficiency anemia | 64 | 8.94 |
Arterial hypertension, controlled | 62 | 8.66 |
Renal failure | 57 | 7.96 |
Coagulopathies | 42 | 5.87 |
Liver disease | 41 | 5.73 |
Diabetes, controlled | 38 | 5.31 |
Obesity | 35 | 4.89 |
Paralysis | 29 | 4.05 |
Lymphoma | 26 | 3.63 |
Blood loss anemia | 14 | 1.96 |
Psychosis | 12 | 1.68 |
Alcohol abuse | 11 | 1.54 |
Drug abuse | 10 | 1.4 |
Peptic ulcer disease | 10 | 1.4 |
Human immunodeficiency syndrome/acquired immunodeficiency syndrome | 1 | 0.14 |
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).